Citation: | Zhu Runqing, . Over-expression of P53 mutant protein in meibomian gland carcinoma[J]. Cancer Research on Prevention and Treatment, 1997, 24(6): 342-343. |
[1] |
Ni Chou, et al. Pathologic classification of meibomian gland carcinomas of eyelids:clinical and pathologic study of 156 cases. Chin Med J. 1979, 92:671.
|
[2] |
施作榕, 链霉菌亲合物素蛋白-生物素酶标免疫组化染色法的初步研究, 中华免疫学杂志, 1986, 2:169.
|
[3] |
Thor AD, Dan H, Moore Ⅱ. et al. Accumulation of P53 Tumor Suppressor Gene Protein:An Independent Marker of Prognosis in Breast Canceer. J Natl Cancer Inst, 1992, 84:845.
|
[4] |
Bosari S, Roncalli M, Viale G, et al. P53 Immunoreac-tivity in inflammatory and neoplastic diseases of the u-terine cervix-J Pathol, 1993, 169:425.
|
[5] |
Shiao YH, Rugge M, Correa P, et al. P53 Alteration in gastric precancerous lesions. Am J Pathol, 1994, 144:511.
|
[6] |
Porter PL, Gown AM. Kramp SG. Widespread P53 overexpression in human malignat tumors. Am J Pathol, 992, 140:145.
|